Inverma Rosa

Dry extract of Ptychopetalum olacoides wood, the active ingredient in Inverma Rosa, is a herbal botanical presented as a dry extract for oral use. It is traditionally employed in herbal preparations, though specific therapeutic claims are not established in modern clinical practice.

GNH USA supplies Inverma Rosa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inverma Rosa, containing a dry extract of Ptychopetalum olacoides wood, is associated with traditional herbal preparations aimed at general wellbeing.

- No established clinical indication: currently not approved for specific therapeutic use.

Inverma Rosa may be associated with mild, reversible reactions in some individuals.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Headache: transient mild headache. - Dizziness: occasional light‑headedness. - Allergic skin reaction: localized rash or itching. - Taste alteration: temporary change in taste perception.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis requiring emergency care. - Hepatic enzyme elevation: abnormal liver function tests. - Hematologic changes: unexplained bruising or bleeding. - Respiratory distress: difficulty breathing not related to allergy. - Cardiovascular events: unexpected palpitations or arrhythmia.

When considering Inverma Rosa, several safety measures should be observed. - Pregnancy: avoid use unless advised by a qualified healthcare professional. - Breastfeeding: discontinue if nursing, as safety has not been established. - Pre‑existing liver disease: use with caution and monitor liver function. - Known allergy to plant extracts: avoid to prevent hypersensitivity reactions. - Concomitant use of anticoagulants: monitor for increased bleeding risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Potential interactions with other substances have been reported for herbal extracts.

Major Interactions (Avoid): - Anticoagulant drugs (e.g., warfarin): may increase bleeding risk. - Immunosuppressants: could alter immune response.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible additive blood‑pressure lowering effect. - Central nervous system depressants: may enhance sedation. - CYP450‑metabolized medications: potential alteration of drug metabolism. - Herbal supplements with similar phytochemicals: risk of additive effects.